Cerebro- and Cardiovascular Risk Reduction with Eprosartan
Barcelona, Spain, 04-Sep-06
Sierra de la, Prof. A., Barcelona, Spain
Welcome and Introduction
Ram, Prof. V., Dallas, United States
Angiotensin Blockade with Eprosartan: Vascular and Functional Implications
Shlyakhto, Prof. E., Saint Petersburg, Russia
Observational Study on Cognitive Function And SBP Reduction (OSCAR): Methodology and Appraisal
Backer De, MD G., Ghent, Belgium
An Attempt to Focus the Limited Resources for Prevention in the Patients at Highest Need
Rupp, Prof. H., Marburg, Germany
Risk Reduction by Preventing Stroke. Need for Blockade of Angiotensin II and Catecholamines?